Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma

NCT: NCT04542616 · COMPLETED

NCT IDNCT04542616
StatusCOMPLETED
Start Date2020-08-13
Completion2024-07-31

Brief Summary

To compare the safety and efficacy of Baerveldt 350 and Ahmed ClearPath 250 tube shunts in lowering IOP in glaucoma patients.

Frequently Asked Questions

What is Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma?

Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma is a clinical trial registered under NCT04542616. Current status: COMPLETED.

What is the status of NCT04542616?

The current status of NCT04542616 (Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma) is: COMPLETED.

When did Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma start?

Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma started on 2020-08-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑